Cantor Fitzgerald Reiterates Overweight Rating on ORIC Pharamceuticals (ORIC) Following Possible ASCO-GU Feb 13 News Title Leak
Tweet Send to a Friend
Cantor Fitzgerald analyst Prakhar Agrawal reiterated an Overweight rating on ORIC Pharamceuticals (NASDAQ: ORIC) following a possible news leak.The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
